CTRI/2025/05/087491尚未招募2 期
A Single Arm Clinical Study to evaluate the efficacy of Eladi Kwath in Raktapradar w.s.r to Menorrhagia.
YMT Ayurved Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2025年6月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- To Evaluate the Efficacy of Eladi Kwath in Raktapradar.
研究概览
简要总结
It is a Single arm clinical study, 42 patients will be taken, Eladi kwath will be given in 2 pal (96ml ~ 100ml), once a day, before food, starting from 5th day of menses upto the next menses for 3 consecutive menstrual cycles
assessment will be done on every 15th day from the 1st baseline visit till 90th day(last visit).
After the last visit USG will be done to evaluate the efficacy of drug
Purpose of study - the purpose of this study is to treat Raktapradar (Menorrhagia) in women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients with cyclic excessive per vaginal bleeding for more than 7days or quantity more than 80ml or both with or without clots during menstrual cycle Hb 10gm or more Patients with Adenomyosis Fibroid uterus less than 3cms endometriosis and pelvic inflammatory disease.
排除标准
- •Patients with IUCD in utero chronic tubo ovarian mass Tubercular Endometritis Granulosa cell tumor of ovary Patients with known case of Systemic disorder like hypertension liver cirrhosis Patients with known case of Hypothyroidism Hyperthyroidism leukemia thrombocytopenia DUB Suspected cases of Spontaneous threatened or incomplete abortion.
结局指标
主要结局
To Evaluate the Efficacy of Eladi Kwath in Raktapradar.
时间窗: To Evaluate the Efficacy of Eladi Kwath in Raktapradar i.e. at baseline, 4 weeks, 8weeks & 12 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerMetastatic Pancreatic CancerNCT03929094Fudan University120
已完成
4 期
Study to Investigate the Efficacy of an Occluding Dentifrice in Providing Relief From Dentine HypersensitivityDentin SensitivityNCT02773758GlaxoSmithKline143
尚未招募
2 期
Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal CancerLocally Advanced Rectal CancerNCT06760520The First Affiliated Hospital of Zhengzhou University40
尚未招募
2 期
IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)Esophageal Squamous Cell Carcinoma (ESCC)PD-1 InhibitorsNCT06078657The First Affiliated Hospital of Zhengzhou University46
尚未招募
2 期
It is a single arm clinical study to see the efficacy of Darvyadi Kwath drug (Ayurvedic formulation)in patients suffering from neuropathic symptoms caused due to chronocity of Diabetes Mellitus disease.CTRI/2024/04/065793Dr Swapnil Balasaheb Kedar